These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 22793971

  • 1. Perioperative management of a pediatric patient with Glanzmann's thrombasthenia during adenoidectomy.
    Duman EN, Saylan S, Cekic B.
    Rev Bras Anestesiol; 2012 Jul; 62(4):548-53. PubMed ID: 22793971
    [Abstract] [Full Text] [Related]

  • 2. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC, Di Minno G, d'Oiron R, Zotz R.
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [Abstract] [Full Text] [Related]

  • 3. NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.
    Franchini M, Lippi G.
    Expert Rev Hematol; 2014 Dec; 7(6):733-40. PubMed ID: 25387838
    [Abstract] [Full Text] [Related]

  • 4. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
    Javed A, Ayyub M, Abrar S, Mansoor M, Khan B, Hussain T.
    J Ayub Med Coll Abbottabad; 2009 Dec; 21(2):171-3. PubMed ID: 20524499
    [Abstract] [Full Text] [Related]

  • 5. Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia.
    Kadowaki S, Makino S, Mohri Y, Awaguni H, Shinozuka J, Imashuku S.
    Blood Coagul Fibrinolysis; 2021 Mar 01; 32(2):155-158. PubMed ID: 33196513
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia.
    Poon MC.
    Thromb Haemost; 2021 Mar 01; 121(3):332-340. PubMed ID: 33124022
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
    Poon MC, Zotz R, Di Minno G, Abrams ZS, Knudsen JB, Laurian Y.
    Semin Hematol; 2006 Jan 01; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
    [Abstract] [Full Text] [Related]

  • 11. The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy.
    Erduran E, Aksoy A, Zaman D.
    Blood Coagul Fibrinolysis; 2009 Apr 01; 20(3):215-7. PubMed ID: 19657319
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
    Hennewig U, Laws HJ, Eisert S, Göbel U.
    Klin Padiatr; 2005 Apr 01; 217(6):365-70. PubMed ID: 16307424
    [Abstract] [Full Text] [Related]

  • 14. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.
    Kale A, Bayhan G, Yalinkaya A, Yayla M.
    J Perinat Med; 2004 Apr 01; 32(5):456-8. PubMed ID: 15493726
    [Abstract] [Full Text] [Related]

  • 15. Feminizing Genitoplasty in a young girl with Glanzmann's thrombasthenia-management of haemostasis.
    Turk KK, Nazir Z.
    J Pak Med Assoc; 2020 Jun 01; 70(6):1084-1085. PubMed ID: 32810113
    [Abstract] [Full Text] [Related]

  • 16. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia.
    Balci YI, Karabulut A, Kabukcu S, Sari I, Keskin A.
    Clin Appl Thromb Hemost; 2011 Aug 01; 17(4):320-2. PubMed ID: 20460355
    [Abstract] [Full Text] [Related]

  • 17. Glanzmann's thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues.
    Di Minno G, Coppola A, Di Minno MN, Poon MC.
    Thromb Haemost; 2009 Dec 01; 102(6):1157-64. PubMed ID: 19967146
    [Abstract] [Full Text] [Related]

  • 18. Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia.
    van Buuren HR, Wielenga JJ.
    Dig Dis Sci; 2002 Sep 01; 47(9):2134-6. PubMed ID: 12353868
    [Abstract] [Full Text] [Related]

  • 19. Perioperative administration of recombinant activated factor VII in a Glanzmann's thrombasthenia patient with platelet refractoriness: case report.
    Bisinotto FMB, Martins LB, de Camargos GP, Bianco MP.
    Braz J Anesthesiol; 2022 Sep 01; 72(6):823-825. PubMed ID: 34852265
    [Abstract] [Full Text] [Related]

  • 20. Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
    Di Minno G.
    Blood Rev; 2015 Jun 01; 29 Suppl 1():S26-33. PubMed ID: 26073366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.